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Abstract
Background: Various routes have been reported with respect to the transmission of human immunodeficiency virus 
(HIV) from one individual to another. But it is not clear whether they alter the clinical expression of the disease. This study 
was conducted to know whether there exists any difference in the occurrence of periodontal lesions among untreated 
HIV subjects who acquired the disease either through intravenous drug abuse or sexual contact and to correlate those 
lesions with immune suppression as indicated by CD 4 T lymphocyte counts.
Materials and Methods: In this cross-sectional study 213 HIV-positive subjects who had not started on Highly Active 
Anti Retroviral Therapy (HAART) were selected and divided into two groups intravenous drug users (IVDU) and non-
IVDU (NIVDU). CD 4 T lymphocyte counts were evaluated and clinical examination was done to detect the presence 
of pathologic periodontal lesions.
Results: Mean probing depth (PD) and clinical attachment level (CAL) are significantly higher in drug users than nondrug 
users. When periodontal lesions are compared with CD 4 cell counts, it is found that significant inverse relation exists 
between linear gingival erythema, necrotizing ulcerative periodontitis, and CD 4 counts, but only in nondrug users.
Conclusion: An inverse correlation between linear gingival erythema, necrotizing ulcerative periodontitis, and CD 4 
counts in NIVDU indicating their reliability as a marker for immune suppression. Periodontitis is more prevalent among 
drug users indicating some difference in disease expression among the groups.
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Introduction
Periodontitis is an infectious disease resulting in inflammation 
within the supporting structures of the teeth, progressive 
attachment loss and bone loss.[1] It is a known fact that oral 
lesions can be a part of HIV infection and lesions involving 
periodontal structures are of no exception. Winkler and 
Murray[2] first reported the relationship between HIV 
infection and periodontal pathology associated with that. 
This was a breakthrough as after this report periodontal 
lesion was given utmost importance in diagnosing HIV-
positive patients. But there exist controversies regarding the 
relationship between periodontal lesions and HIV disease 
progression, as evaluated by CD 4 T lymphocyte counts. [2,3] 
It is a well-known fact that HIV has four main routes of 
transmission and the most common being intravenous 
drug abuse and promiscuous sexual contact. Reports in the 
medical literature, although with conflicting results, have 
shown that the systemic presentation of this illness might 
vary according to the route of transmission.[4-6] Whereas 
studies by Palenicek et al.[4] and Margolick et al.[5] showed 
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increased occurrence of oral candidiasis in drug users and 
homosexuals respectively, study by Routy et al.[6] proved that 
no such predilection exists between these two groups with 
respect to disease expression. But these kinds of reports are 
lacking in periodontal literature, in spite of such reports 
existing with respect to oral lesions seen in HIV infection. [7- 9] 
Thus, the aims and objectives of this study were not only 
to know whether there exists a relationship between the 
periodontal lesions and immune suppression as indicated by 
CD 4 T lymphocyte counts but also to find whether there 
exists any difference in the occurrence of periodontal lesions 
among the above-mentioned two groups in individuals who 
were not under Highly Active Anti Retro-viral Therapy 
(HAART) as HAART is found to improve the overall 
immune status of HIV-positive individuals.[10,11]
Materials and Methods
This study was conducted at Anti Retroviral Therapy Centre, 
Government General Hospital, Chennai from June 2007 to 
August 2008. All the patients who were diagnosed to have 
HIV illness (positive for HIV-1 or 2 antibody, confirmed by 
at least two diagnostic tests, one being confirmatory test), 
reporting to this centre, were screened, of which subjects 
who met the inclusion criteria were allowed to participate in 
this study. The inclusion criteria to participate in this study 
were gender of either sex, patients who acquired this illness 
either through intravenous drug abuse or sexual contact 
and patients who have either good or fair oral hygiene (as 
determined by simplified oral hygiene index).[12] Exclusion 
criteria include smokers, pregnant females, patients who had 
oral prophylaxis within a period of 6 months, history of any 
systemic illness other than HIV, subjects who acquired the 
disease through both the routes and people who have started 
on HAART. Individuals who acquired the illness through 
other established routes or whose route of acquisition was 
unclear were also excluded from the study. All the details 
regarding the route of acquisition and socio demographic 
data were asked individually, by interviewing them in a 
private room by a single examiner (A.T.R.) in their regional 
language. All the patients were asked to give their consent 
after being informed about the study. This study got the 
approval from the Institutional ethical Committee, Madras 
Medical College, Chennai. A total of 213 individuals who 
met the above said inclusion criteria were divided into 
two groups [intra venous drug users (IVDU) and those 
acquired through sexual contact (NIVDU)] and subjected 
to clinical examination, which included measurement of 
probing pocket depth (PD), clinical attachment level (CAL) 
and examination to detect the presence of periodontal 
lesions related to HIV infection namely linear gingival 
erythema (LGE), necrotizing ulcerative gingivitis (NUG), 
and necrotizing ulcerative periodontitis (NUP) by a single 
examiner (A.T.R). Other oral lesions that were present were 
also recorded. Probing depth was measured using a probe 
with William’s marking. Three measurements on the buccal 
surface and three on the palatal/lingual surface were made 
for each tooth. CAL was calculated using probing depth 
keeping cemento enamel junction as a reference point. [13] 
LGE, NUG, and NUP were diagnosed according to the 
standardized criteria given by Axell et al.[14]  Briefly, LGE was 
diagnosed when there is a distinct, complete erythematous 
band present from one papilla to adjacent papilla and 
extending to at least 2 mm from the gingival margin. NUG 
was diagnosed when at least one papilla appears ulcerated or 
had a crater like appearance and the patient had moderate 
to severe pain or history of pain in the area within the last 
6 months. NUP was diagnosed by same criteria except, 
in addition to the above-said features, necrotic alveolar 
bone was exposed or there was evidence of at least 3 mm 
of probing attachment loss in the interproximal area. CD 
4 T cell counts were estimated by Flow Cytometry (BD 
FACSAria, Beckton Dickinson Pvt. Ltd., India) for all these 
patients,1-2 days prior, or on the day of examination. Data 
thus collected were analyzed statistically using SPSS. A 
Student t-test was used to compare PD and CAL between 
the groups and a chi-square test was employed to compare 
the periodontal lesions between the two groups. Kendall’s 
t correlation coefficient was used to know the correlation 
between the lesions and declining CD 4 T cell counts. 
Results were considered to be significant at a P value < 0.05.
Results
Our study comprised 213 untreated HIV-positive 
individuals divided into two groups, IVDU (n=40) 
and NIVDU (n=173). NIVDU included both males 
and females between the age group of 25-60 years with 
mean age of 34.08 + 9.08 years, including homosexuals, 
bisexuals, and heterosexuals, whereas IVDU consisted of 
only males within the age group of 2448 years with mean 
age of 37.1 + 7.07 years. Lack of females in the drug user 
group is due to the reduced number of female drug users, 
especially in our part of the country.
When the prevalence of periodontal lesions was considered 
in the entire cohort under study, LGE was seen in 45.5%, 
NUG in 1.4%, and NUP in 1.9% of the individuals. The 
prevalence of these lesions in each group is shown in Table 1. 
Oral lesions seen in our study group were oral candidiasis, 
oral hairy leukoplakia, and median rhomboid glossitis. 
Table 1: Comparison of periodontal lesions between 
IVDU and NIVDU
Lesion IVDU (n=40) (%) NIVDU (n=173) (%) P value
LGE 21 (52.5) 76 (43.9) 0.32
NUG 01 (2.5) 02 (1.2) 0.51
NUP 01 (2.5) 03(1.7) 0.74
IVDU = Intra venous drug users; NIVDU = Non intravenous drug users ; 
LGE = Linear gingival erythema; NUG = Necrotizing ulcerative gingivitis; 
NUP = Necrotizing ulcerative periodontitis
351Nigerian Journal of Clinical Practice • Jul-Sep 2012 • Vol 15 • Issue 3
Aravindhan, et al.: Periodontal lesions in HIV positive drug individuals
When periodontal parameters were compared between 
both the groups, PD ranged from minimum of 2.31 mm to 
maximum of 5 mm in the group IVDU, whereas it ranged 
from 2.1 mm to 4.52 mm in the case of NIVDU. CAL 
ranged from 2.3 to 6.85 mm in the group IVDU and 2.4 
to 6.2 mm in NIVDU. When the periodontal parameters, 
namely PD and CAL, were compared between both the 
groups, CAL was seen more in IVDU than in NIVDU as 
shown in Table 2. 
No periodontal lesion showed significant prediction toward 
IVDU or NIVDU.
CD 4 T cell was classified into three groups, counts above 
than 500, between 200 and 500, and counts less than 
199 cells/mm3. The number of individuals displaying 
periodontal lesions and their stratification according to the 
CD 4 counts were shown in Table 3. When the decrease in CD 
4 T cell counts was correlated with CAL or pocket depth, no 
statistically significant correlation was found to exist in both 
the groups as shown in Table 4, but there existed a significant 
inverse correlation between LGE and NUP and CD 4 counts, 
but only in the group NIVDU as shown in Table 5.
Discussion
Acquired immunodeficiency syndrome is a universal epidemic 
affecting all the domains of population. It is a well-established 
fact that oral manifestations might be the initial presentation 
of this illness. Among the various oral lesions, periodontal 
manifestations have important implications as they are 
supposed to be strongly associated with this infection. Some 
of the periodontal lesions like NUP tend to occur more as the 
CD 4 count decreases, indicating the reliability of these lesions 
in indicating immune suppression.[15] 
Patients not under HAART tend to have more lesions than 
patients under HAART and hence we decided to study 
those people in whom the clear clinical manifestation of 
HIV infection can be studied.[10] We aimed correlating these 
lesions with CD 4 counts in an attempt to know the effect of 
immune suppression on periodontal tissues, as CD 4 counts 
show the true immune status of these individuals. When 
CD 4 counts were correlated with all the lesions identified, 
we found no correlation between declining CD 4 counts 
and pocket depth or CAL in both the groups, similar to the 
findings of Goncalves et al.[16] 
But in IVDU, we found an inverse relationship between LGE, 
NUP and depleting CD 4 counts. Even though Ceballos-
salobrena et al.[17] and Margiotta et al.[18] showed similar 
results, the above-mentioned studies do no differentiate 
the study group into intravenous and nonintravenous drug 
users, whereas we have attempted to differentiate the study 
group into drug users and nondrug users.
With respect to NUP, Glick et al[15] mentioned that NUP 
should be considered for inclusion in AIDS surveillance 
definition. In our study, though NUP does not correlate 
with declining CD 4 counts in the drug users, the patients 
who showed NUP had CD 4 value less than 200 cells/ mm3. 
Thus this study depicts the occurrence of periodontal lesions 
in HIV patients unmasked by HAART therapy. The reason 
for this difference between our study and the study by Glick 
et al.[15] might be that the study group in ours comprised 
patients not under HAART, whereas the ART status of the 
latter was not mentioned. But this proves the validity of the 
statement given by Glick et al.[15] that NUP can be considered 
as a marker of immune suppression and further studies with 
increased sample size are required to confirm this.










PD 2.59 ± 0.46 2.44 ± 0.37 0.03*
CAL 3.22 ± 0.80 2.85 ± 0.70 0.004*
*Statistically significant.
Table 3: Stratification of lesions according to CD 4 
counts in two groups
Lesion IVDU n=40 (%) NIVDU n=173 (%)
LGE NUG 
NUP
>500 cells/mm3 - 06 (15) 
200-499 cells/mm3 - 09 (70) 
<199 cells/mm3 - 06 (15) 
>500 cells/mm3 - 0
200-499 cells/mm3 - 01 (2.5)
<199 cells/mm3 - 0
>500 cells/mm3 - 0
200-499 cells/mm3 - 0
<199 cells/mm3 - 01 (2.5)
>500 cells/mm3 - 23 (13.2)
200-499 cells/mm3 - 32 (18.4)
<199 cells/mm3 - 21 (12.1)
>500 cells/mm3 - 0
200-499 cells/mm3 - 02 (1.15)
<199 cells/mm3 - 01 (2.5)
>500 cells/mm3 - 0
200-499 cells/mm3 - 0
<199 cells/mm3 - 03 (1.73)
LGE = Linear gingival erythema; NUG = Necrotizing ulcerative gingivitis; 
NUP = Necrotizing ulcerative periodontitis
Table 4: Correlation between periodontal parameters 










PD -0.14 0.9 -0.06 0.2
CAL -0.16 0.19 -0.07 0.2
PD = Pocket depth; CAL = Clinical attachment level
Table 5: Correlation between Periodontal lesions and 










LGE 0.06 0.6 -0.14 0.04*
NUG -0.19 0.19 -0.09 0.2
NUP -0.19 0.19 -0.19 0.009*
*Statistically significant.
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This also denotes that even though the organism might be 
the same, the route by which this organism enters the tissue 
might play a role in disease expression. There are studies in 
the literature which associated oral and periodontal lesions 
in HIV infected individuals,[17-19] but very few studies have 
been attempted to find difference in disease expression in 
periodontal tissues among the above said groups.[20,21] In the 
medical literature, there are many studies related to this issue.
[4,5,6,22] But there are scanty studies focusing at this issue with 
respect to periodontal lesions and to the best of our knowledge, 
no studies have been done in our population. Study by Pehrson 
et al.[22] showed the rate of progression of AIDS indicating 
illness from HIV-positive state is more with homosexuals than 
in drug users. With respect to periodontal tissues, study by 
Friedman et al.[20] showed no difference in disease expression 
among the groups, but we found attachment loss is seen more 
with IVDU compared to NIVDU, indicating not only severe 
periodontal destruction in drug users, but also denotes route 
of transmission might play an important role in the initiation 
of immune response. [22] One important factor to be considered 
while interpreting these results is that the number of drug users 
in our study is very less owing to their reduced prevalence in our 
part of the country. In addition females are not included in the 
drug users group restricting us to find the influence of gender 
in interpretation of the results. This is the major limitation of 
this study, and further studies will be done in this aspect. But 
the results obtained through this preliminary study cannot be 
under estimated as this shows there is difference in disease 
expression between the two groups. This difference can be due 
to the transmission route determining the immune response, 
as immune response might differ according to the route of 
disease acquisition.[23] This occurs as the body mounts immune 
response to disparate viral strains operating in drug users.[22] 
This denotes the importance of route of acquisition but further 
studies must be done in this aspect to support this hypothesis.
When we compare other oral lesions among the groups, 
none of the lesions showed predilection towards any of the 
group, showing similar disease expression among the groups 
which is similar to the study by Routy et al.[5] where they 
showed the disease expression is same in both drug users 
and non drug users.
Before making a final conclusion, it becomes essential 
to discuss about the microbial flora, as, the presence of 
syncytium inducing HIV serotype can lead to accelerated 
CD4 count depletion, immune suppression and hence more 
periodontal destruction.[23] This study thus opens the view 
stating that route of disease acquisition might play a role in 
the disease expression and future studies are required in this 
direction to identify the actual mechanism underlying this.
Conclusion
It can be inferred from our study that LGE and NUP are the 
two lesions which are inversely correlated with CD4 counts, 
but only in NIVDU. This and the increased prevalence of 
periodontal destruction in IVDU as indicated by increased 
CAL show evidence route of transmission might play a role 
in clinical expression of the disease. 
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